AAVivo, a Delaware-registered biotechnology company focused on next-generation AAV-based gene therapies and supported by Virovek, today announced that it will host a sponsored symposium at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting, taking place May 11–15, 2026, in Boston, Massachusetts....
Join Virovek and over 200 biopharma and biotech executive leaders at our annual biomanufacturing conference! Over our two-day event, top biopharma executives and solution providers come together to discuss emerging key trends, challenges, opportunities, and innovations in the biotechnology industry....
Join Virovek at TThe American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for gene and cell therapy professionals. The meeting is the best place for people in the field to learn from the latest scientific research, stay current on new technologies, and make career-advancing...
Virovek, a commercial-stage biotechnology company specializing in the development, manufacturing and sale of custom-made AAV- and lentivirus-based vectors for therapeutic development, today announced that the Company has appointed Peter L. Hoang as its Chief Executive Officer....